Log in
Enquire now
‌

US Patent 12006361 Albumin binding domain fusion proteins

Patent 12006361 was granted and assigned to Sonnet Biotherapeutics, Inc. on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Sonnet Biotherapeutics, Inc.
Sonnet Biotherapeutics, Inc.
0
Date Filed
May 4, 2021
0
Date of Patent
June 11, 2024
0
Patent Applicant
Sonnet Biotherapeutics, Inc.
Sonnet Biotherapeutics, Inc.
0
Patent Application Number
17307884
0
Patent Citations
‌
US Patent 9321832 Ligand
0
‌
US Patent 9790475 Human serum albumin binding compounds and fusion proteins thereof
0
‌
US Patent 9897077 Solar automatic heat collecting and equalizing tube, automatic heat equalizing trough-type module, solar-thermal complementary power generation system comprising the same, and power generation method using the same
0
‌
US Patent 9803004 Albumin binding antibodies and binding fragments thereof
0
‌
US Patent 8188223 Serum albumin binding proteins
0
‌
US Patent 8679496 Anti-serum albumin single variable domains
0
‌
US Patent 8921528 Bispecific fusion antibodies with enhanced serum half-life
0
‌
US Patent 9012609 Anti-serum albumin binding variants
0
‌
US Patent 9175071 Anti-serum albumin binding variants
0
Patent Inventor Names
Haomin Huang
0
John K. Cini
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12006361
0
Patent Primary Examiner
‌
Hong Sang
0
CPC Code
‌
C07K 2317/622
0
‌
C07K 2319/00
0
‌
A61K 39/00114
0
‌
C07K 14/76
0
‌
A61K 39/3955
0
‌
C07K 14/7155
0
‌
C07K 16/244
0
‌
A61K 2039/6081
0
‌
C07K 16/18
0

Find more entities like US Patent 12006361 Albumin binding domain fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.